StreetInsider.com News Articles

Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies

Wed, 04 Nov 2026 13:30:00 -0500

The patent acquisition is intended to support the Company’s longer-term healthcare and biomedical research and development strategy. Separately, the Company continues to advance negotiations regarding its proposed strategic investment in Future Biotechnology Group Co., Limited, as previously announced

HONG KONG, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the “Company”) today announced that it has entered into a definitive purchase agreement (the “Agreement”) with Future Biotechnology Group Co., Limited for the acquisition (the “Acquisition”) of three tumor cell-related medical technology patents covering areas including oncology diagnosis and treatment, cell detection and bioengineering,

Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies

Wed, 04 Nov 2026 13:30:00 -0500

Form 6-K Ping An Biomedical Co., For: Oct 30

Fri, 30 Oct 2026 16:34:00 -0500

si-local-file:///var/storage/secattach/20261030/27266662.html

Form 6-K Ping An Biomedical Co., For: Oct 26

Mon, 26 Oct 2026 08:30:00 -0500

si-local-file:///var/storage/secattach/20261026/27231210.html

Form F-3 Ping An Biomedical Co.,

Fri, 23 Oct 2026 17:01:00 -0500

si-local-file:///var/storage/secattach/20261023/27228516.html

Form 6-K Ping An Biomedical Co., For: Oct 22

Thu, 22 Oct 2026 17:00:00 -0500

si-local-file:///var/storage/secattach/20261022/27223381.html

Ping An Biomedical plans to acquire three oncology patents for up to $2.5M

Thu, 22 Oct 2026 15:30:09 -0500

Ping An Biomedical Co., Ltd. (Nasdaq: PASW) has signed a letter of intent with Future Biotechnology Group Co., Limited to acquire three tumor cell-related medical technology patents for consideration ranging from $2 million to $2.5 million, according to a press release.

The patents cover oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies. The transaction remains subject to due diligence, the negotiation and execution of definitive agreements, and applicable regulatory requirements.

The company stated it does not expect the planned acquisition to generate material revenue in the near term. Management said the patents are intended to form

Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio

Thu, 22 Oct 2026 15:30:00 -0500

HONG KONG, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the “Company”) today announced its entry into a letter of intent with Future Biotechnology Group Co., Limited (the “Letter of Intent”), for the planned acquisition (the “Planned Acquisition”) of three tumor cell-related medical technology patents covering areas including oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies, for a consideration ranging from US 2 million to US 2.5 million. The Planned Acquisition shall be subject to a final acquisition agreement to be subsequently prepared and executed by

Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio

Thu, 22 Oct 2026 15:30:00 -0500

Ping An Biomedical completes 1-for-40 reverse stock split

Wed, 21 Oct 2026 11:00:16 -0500

Ping An Biomedical Co., Ltd. (Nasdaq: PASW) announced that its board of directors approved a 1-for-40 reverse stock split of the company's class A and class B ordinary shares, with split-adjusted trading on the Nasdaq Capital Market set to begin on October 23, 2026.

Under the terms of the reverse stock split, every 40 issued and unissued class A ordinary shares will be automatically combined into one class A ordinary share, and every 40 class B ordinary shares will be combined into one class B ordinary share. The par value of each share class will change from $0.0000625 to $0.0025. Fractional

Form 6-K Ping An Biomedical Co., For: Oct 21

Wed, 21 Oct 2026 11:00:00 -0500

si-local-file:///var/storage/secattach/20261021/27214900.html

Ping An Biomedical Announces 1-for-40 Reverse Stock Split

Wed, 21 Oct 2026 11:00:00 -0500

Class A Ordinary Shares Expected to Begin Trading on a Split-Adjusted Basis on October 23, 2026

HONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (“Ping An Bio” or the “Company”) announced that its board of directors has approved a 1-for-40 reverse stock split of the Company’s class A ordinary shares and class B ordinary shares.

The Company’s class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at the opening of trading on October 23, 2026. The shares will continue to

Ping An Biomedical Announces 1-for-40 Reverse Stock Split

Wed, 21 Oct 2026 11:00:00 -0500

Class A Ordinary Shares Expected to Begin Trading on a Split-Adjusted Basis on October 23, 2026

The Company’s class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at the opening of trading on October 23, 2026. The shares will continue to

Form 6-K Ping An Biomedical Co., For: Mar 31

Fri, 11 Sep 2026 09:01:00 -0500

si-local-file:///var/storage/secattach/20260911/27051157.html

Form 6-K Ping An Biomedical Co., For: Aug 07

Fri, 07 Aug 2026 16:30:00 -0500

si-local-file:///var/storage/secattach/20260807/26891516.html

Ping An Biomedical signs deal targeting RMB 500M in sales

Wed, 22 Jul 2026 09:50:07 -0500

Ping An Biomedical Co., Ltd. (Nasdaq: PASW) has signed a strategic cooperation agreement with Yuan Sheng Mei Yan Health Services (Hainan) Co., Ltd., according to a press release statement. Under the agreement, Yuan Sheng Mei Yan will serve as a channel development service provider for Ping An Biomedical, with a combined target of RMB 500 million in cumulative sales over three years.

Under the arrangement, Yuan Sheng Mei Yan will support Ping An Biomedical in expanding product channels, promoting market outreach, and facilitating service delivery, drawing on its operations in health management, wellness services, and high-end customer services. Ping An Biomedical

Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years

Wed, 22 Jul 2026 09:50:00 -0500

HONG KONG, July 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (hereinafter referred to as “Ping An Biomedical”) announced that it has formally signed a strategic cooperation agreement with Yuan Sheng Mei Yan Health Services (Hainan) Co., Ltd. (hereinafter referred to as “Yuan Sheng Mei Yan”). Under the agreement, Yuan Sheng Mei Yan will serve as a channel development service provider for Ping An Biomedical. The two parties will engage in deep cooperation in the broader health and wellness services market, with a shared goal of achieving cumulative sales of RMB 500 million

Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years

Wed, 22 Jul 2026 09:50:00 -0500

Form 6-K Ping An Biomedical Co., For: Jul 20

Mon, 20 Jul 2026 09:25:00 -0500

si-local-file:///var/storage/secattach/20260720/26787993.html

Form 6-K Ping An Biomedical Co., For: May 27

Wed, 27 May 2026 17:00:00 -0500

si-local-file:///var/storage/secattach/20260527/26558862.html

Form 3 Ping An Biomedical Co., For: Oct 14 Filed by: Liu Pijun (PJL)

Wed, 08 Apr 2026 07:33:00 -0500

si-local-file:///var/storage/secattach/20260408/26286168.html

Form 3 Ping An Biomedical Co., For: Oct 14 Filed by: Yang Hongli (HLY)

Wed, 01 Apr 2026 06:07:00 -0500

si-local-file:///var/storage/secattach/20260401/26254268.html

Form 3 Ping An Biomedical Co., For: Oct 14 Filed by: Liu Xianzhi (XZL)

Wed, 01 Apr 2026 06:07:00 -0500

si-local-file:///var/storage/secattach/20260401/26254279.html

Form 6-K Ping An Biomedical Co., For: Mar 19

Thu, 19 Mar 2026 10:50:00 -0500

si-local-file:///var/storage/secattach/20260319/26190898.html

Form 6-K Ping An Biomedical Co., For: Mar 19

Thu, 19 Mar 2026 10:50:00 -0500

si-local-file:///var/storage/secattach/20260319/26190898.html